What is gastric atypical hyperplasia
Gastric atypia is an abnormal proliferation of gastric mucosal epithelial cells and is a type of precancerous lesion. In recent years, with the improvement of health awareness and the popularization of gastroscopy, this concept has gradually entered the public eye. This article will combine the hot health topics on the Internet in the past 10 days to provide you with a detailed analysis of the definition, classification, risk factors and preventive measures of gastric atypical hyperplasia.
1. Definition and classification of gastric atypical hyperplasia
Gastric atypical hyperplasia refers to abnormal changes in the morphology and structure of gastric mucosal epithelial cells, but has not yet reached the criteria for malignant tumors. According to the degree of cell atypia, it can be divided into the following two categories:
| Type | Features | cancer risk |
|---|---|---|
| low grade atypical hyperplasia | Mildly abnormal cell morphology and disordered structure | 5%-10% |
| high grade atypical hyperplasia | The cells were significantly atypical and had increased mitotic figures. | 60%-85% |
2. Recent hot topics: the relationship between gastric atypical hyperplasia and Helicobacter pylori
According to discussions in the medical field in the past 10 days, Helicobacter pylori (Hp) infection has been confirmed as one of the main causes of gastric atypical hyperplasia. The data shows:
| research sample | Proportion of Hp-positive patients | Proportion of developing atypical hyperplasia |
|---|---|---|
| 1000 patients with chronic gastritis | 78.3% | 12.7% |
| 500 gastric ulcer patients | 91.2% | 24.5% |
3. Typical symptoms and diagnostic methods
Gastric atypical hyperplasia usually has no obvious specific symptoms, but based on recent clinical reports, the following symptoms need to be alerted:
| Symptom frequency | clinical manifestations | Prompt meaning |
|---|---|---|
| High frequency (>60%) | Upper abdominal pain and fullness | Nonspecific gastritis manifestations |
| Medium frequency (30%-50%) | Acid reflux, belching | May be accompanied by gastric mucosal damage |
| Low frequency (<20%) | Vomiting blood, black stool | Indicates possible progression to tumors |
The diagnostic gold standard isGastroscopy + pathological biopsy, the recently discussed chromoendoscopy (NBI) technology can improve the early detection rate.
4. Prevention and control strategies (combined with the latest guidelines)
According to the 2023 "Expert Consensus on Early Gastric Cancer Screening Process in China" recommendations:
| risk stratification | Interventions | Follow-up period |
|---|---|---|
| low risk group | Eradicate HP and improve lifestyle | Gastroscopy review every 3 years |
| Medium risk group | Endoscopic mucosal resection (EMR) | Review every 6-12 months |
| high risk groups | Endoscopic submucosal dissection (ESD) | Review every 3-6 months |
5. Nutrition and prevention hot spots
Recent research suggests that the following food ingredients may reduce your risk:
| food category | active ingredient | protection mechanism |
|---|---|---|
| Cruciferous vegetables | Isothiocyanate | Inhibit inflammatory factors |
| green tea | Tea polyphenols | antioxidant effect |
| garlic | Allicin | Inhibit Hp growth |
Conclusion
Gastric atypical hyperplasia is a critical window period for the prevention and treatment of gastric cancer. Recently, the medical community has placed special emphasis onPeople over 40 years old, those with a family history of gastric cancer, and those with long-term Hp infectionScreening should be done regularly. With standardized treatment and scientific management, most patients can achieve disease reversal. It is recommended to develop a personalized prevention and control plan based on your own risk factors.
check the details
check the details
en
